Hospital Corporation of China Limited (Hospital Corp) has scheduled its board meeting for 25 August 2026. Key items on the agenda include approval of the unaudited interim results for the six months ended 30 June 2026 and deliberation on the declaration of an interim dividend.
The announcement, released on 13 August 2026, confirms that the board will also authorise publication of the interim financial report following its review. Any dividend decision will be disclosed after board approval.
Hospital Corp’s current board comprises three executive directors—Lang Xiaofeng (Chief Executive Officer), Pu Chengchuan and Pan Jianli; three non-executive directors—Cao Yonggang, Liu Lu and Wang Nan; and two independent non-executive directors—Dang Jinxue and Zhou Xiangliang.